Gainers
- TherapeuticsMD (NASDAQ:TXMD) shares rose 4466.2% to $7.0 during Monday's pre-market session. The company's market cap stands at $60.6 million.
- Better Therapeutics (NASDAQ:BTTX) stock rose 33.51% to $2.51. The market value of their outstanding shares is at $59.2 million.
- LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 30.88% to $0.65. The market value of their outstanding shares is at $21.4 million.
- FibroGen (NASDAQ:FGEN) stock rose 10.46% to $9.29. The company's market cap stands at $866.6 million. As per the press release, Q1 earnings came out today.
- Palisade Bio (NASDAQ:PALI) shares moved upwards by 8.88% to $0.56. The market value of their outstanding shares is at $10.2 million.
- Surface Oncology (NASDAQ:SURF) stock rose 8.61% to $2.27. The company's market cap stands at $123.9 million.
Losers
- The Oncology Institute (NASDAQ:TOI) shares declined by 21.7% to $6.9 during Monday's pre-market session. The market value of their outstanding shares is at $505.4 million.
- ContraFect (NASDAQ:CFRX) shares fell 14.03% to $3.25. The market value of their outstanding shares is at $127.8 million.
- GlucoTrack (NASDAQ:GCTK) stock fell 13.93% to $2.41. The market value of their outstanding shares is at $37.2 million.
- Reshape Lifesciences (NASDAQ:RSLS) stock decreased by 11.83% to $0.67. The company's market cap stands at $2.3 million.
- Immuron (NASDAQ:IMRN) shares declined by 11.12% to $2.5. The market value of their outstanding shares is at $14.2 million.
- Avenue Therapeutics (NASDAQ:ATXI) shares decreased by 11.03% to $0.3. The market value of their outstanding shares is at $6.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
